{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:18:15Z","timestamp":1792682295517,"version":"4.5.0"},"reference-count":11,"publisher":"BMJ","issue":"12","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2013,11,19]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      This study assessed the performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT\/NG and the COBAS Amplicor for\n                      <jats:italic>Chlamydia trachomatis<\/jats:italic>\n                      and\n                      <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                      detection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A cross-sectional study design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Izore, Centre for Diagnosing Infectious Diseases in Friesland, the Netherlands, tested samples sent from regional sexually transmitted infection (STI) outpatient clinics and regional hospitals from the province Friesland, the Netherlands.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Samples were collected from 292 men and 835 women. These samples included 560 urine samples and 567 urethral\/cervicovaginal samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>\n                      The primary outcome measure is\n                      <jats:italic>C trachomatis<\/jats:italic>\n                      infection. No secondary outcome measures are available.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The sensitivity, specificity, positive predicative value (PPV) and negative predictive value (NPV) for\n                      <jats:italic>C trachomatis<\/jats:italic>\n                      detection in urine samples using the Presto CT-NG assay were 100%, 99.8%, 98.1% and 100%, respectively; for the Lightmix Kit 480 HT CT\/NG: 94.2%, 99.8%, 96.1% and 99.4%, respectively; for the COBAS Amplicor: 92.3%, 99.6%, 96% and 99.2%, respectively. The sensitivity, specificity, PPV and NPV for\n                      <jats:italic>C trachomatis<\/jats:italic>\n                      detection in urethral\/cervicovaginal swabs using the Presto CT-NG assay and the COBAS Amplicor were 100%, 99.8%, 97.7% and 100%, respectively; for the Lightmix Kit 480 HT CT\/NG: 100%, 99.6%, 97.7% and 100%, respectively. Calculations for\n                      <jats:italic>N gonorrhoeae<\/jats:italic>\n                      could not be made due to a low prevalence.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      All three assays had a high sensitivity, specificity, PPV and NPV for\n                      <jats:italic>C trachomatis<\/jats:italic>\n                      , with best performance for the Presto CT-NG assay.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2013-003607","type":"journal-article","created":{"date-parts":[[2013,12,31]],"date-time":"2013-12-31T20:13:17Z","timestamp":1388520797000},"page":"e003607","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Detection of\n                    <i>Chlamydia trachomatis<\/i>\n                    and\n                    <i>Neisseria gonorrhoeae<\/i>\n                    in an STI population: performances of the Presto CT-NG assay, the Lightmix Kit 480 HT CT\/NG and the COBAS Amplicor with urine specimens and urethral\/cervicovaginal samples"],"prefix":"10.1136","volume":"3","author":[{"given":"T A","family":"Schuurs","sequence":"first","affiliation":[{"name":"Izore, Centre for Infectious Diseases Friesland, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S P","family":"Verweij","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F L","family":"Weel","sequence":"additional","affiliation":[{"name":"Izore, Centre for Infectious Diseases Friesland, Leeuwarden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ouburg","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S A","family":"Morr\u00e9","sequence":"additional","affiliation":[{"name":"Laboratory of Immunogenetics, Department of Medical Microbiology and Infection Control, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Faculty of Health, Medicine & Life Sciences, Department of Genetics and Cell Biology, Research Institute GROW, Institute of Public Health Genomics, University of Maastricht, Maastricht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,12,30]]},"reference":[{"key":"2025121400390974000_3.12.e003607.1","unstructured":"Trienekens SCM Koedijk FDH Van den Broek IVF . Sexually transmitted infections, including HIV, in the Netherlands in 2011. Bilthoven, The Netherlands: National Institute for Public Health and the Environment; 2012, Report No.: 201051001."},{"key":"2025121400390974000_3.12.e003607.2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmp035"},{"key":"2025121400390974000_3.12.e003607.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1983.03340230057031"},{"key":"2025121400390974000_3.12.e003607.4","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1128\/jcm.35.10.2628-2633.1997","article-title":"Comparison of three commercially available amplification assays, AMP CT, LCx, and COBAS AMPLICOR, for detection of Chlamydia trachomatis in first-void urine","volume":"35","author":"Goessens","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2025121400390974000_3.12.e003607.5","doi-asserted-by":"publisher","DOI":"10.2353\/jmoldx.2007.070011"},{"key":"2025121400390974000_3.12.e003607.6","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181644bc9"},{"key":"2025121400390974000_3.12.e003607.7","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1128\/JCM.38.4.1679-1680.2000","article-title":"Pooling of urine specimens for detection of asymptomatic Chlamydia trachomatis infections by PCR in a low-prevalence population: cost-saving strategy for epidemiological studies and screening programs","volume":"38","author":"Morre","year":"2000","journal-title":"J Clin Microbiol"},{"key":"2025121400390974000_3.12.e003607.8","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009089"},{"key":"2025121400390974000_3.12.e003607.9","doi-asserted-by":"publisher","DOI":"10.2307\/2276774"},{"key":"2025121400390974000_3.12.e003607.10","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46762-0"},{"key":"2025121400390974000_3.12.e003607.11","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02595-10"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2013-003607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T08:39:21Z","timestamp":1765701561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2013-003607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":11,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,30]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/bmjopen-2013-003607"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2013-003607","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}